Full text is available at the source.
Abstract
High-dose glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used for obesity management.
- The perioperative safety of GLP-1 RAs in patients undergoing anterior cervical discectomy and fusion (ACDF) is not well established.
- Potential effects of GLP-1 RAs on fusion-related outcomes after ACDF remain unclear.
- Further investigation is needed to understand the implications of GLP-1 RA use in surgical settings.
Simplified